Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn’s disease
Abstract Background: Clinically, the ability to distinguish which Crohn’s disease patients can benefit from Adalimumab is limited. Aims: This study aimed to develop a model for predicting clinical remission probability for Crohn’s disease patients with Adalimumab at 12 weeks. The model assists clini...
Saved in:
Main Authors: | Fang Wang, He Zhou, Yujie Zhang, Yu Da, Tiantian Zhang, Yanting Shi, Tong Wu, Jie Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-82855-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Innovative Assessment of Crohn’s Disease: An Activity Prediction Tool Combining Laboratory Data and Imaging [Letter]
by: Wang F, et al.
Published: (2025-02-01) -
Systemic Immune-Inflammation Index: A Promising, Non-Invasive Biomarker for Crohn’s Disease Activity and Severity Assessment
by: Deng Y, et al.
Published: (2025-01-01) -
Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01) -
Efficacy of ileostomy in Crohn's disease of the large intestine with perianal involvement
by: Yu. A. Shelygin, et al.
Published: (2011-12-01) -
Development and external validation of a nomogram for the early prediction of acute kidney injury in septic patients: a multicenter retrospective clinical study
by: Qin-Yue Su, et al.
Published: (2024-12-01)